Table 1

 Disease related characteristics of 90 patients with rheumatoid arthritis with or without etanercept

CharacteristicEtanercept group (n = 52)Control group (n = 38)p Value
Values are median (range).
DMARD, disease modifying antirheumatic drug.
Age (years)53 (20 to 80)52 (20 to 69)0.223
Women (%)9087
Duration of disease (years)9.5 (1 to 20)8 (1 to 21)0.882
Methotrexate (mg)7.5 (0 to 20)7.5 (0 to 20)0.551
DMARDs except methotrexate (n)1.5 (1 to 3)1 (1 to 3)0.954